The EJ Technical Guidance will enable analysts to provide a better understanding of how human health effects are distributed under baseline conditions and regulatory options being considered. This comparison will help decision makers understand the distribution of health effects and allow them to make better decisions with respect to various population groups of concern.
How will this guidance affect human health?
Have more questions? Submit a request